Further research on the specific mechanisms and regulatory pathways of MAFB and CX3CR1 mediated by macrophages in NAFLD development will help enhance our understanding of the pathogenesis of NAFLD and potentially provide new targets for its treatment. This evidence concerns the gene CX3CR1 and metabolic dysfunction-associated steatotic liver disease.